Sign In
Buy TDOC
$7.09
-0.450 (-5.97%)
At Close: Jun 03, 2026
Teladoc Health Q4 Loss Widens on Soft Integrated Care Unit
01:15pm, Thursday, 27'th Feb 2025
TDOC expects revenues in the Integrated Care segment to witness 0-3% growth on a year-over-year basis.
Teladoc Q4 Earnings: A Waiting Game For Investors (Rating Downgrade)
10:18am, Thursday, 27'th Feb 2025
Teladoc Health, Inc.'s disappointing guidance and lack of revenue growth have led me to adopt a neutral stance on TDOC stock despite its cheap valuation at 7x forward free cash flow. My investment str
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
09:30am, Thursday, 27'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC) Such investors are ad
Teladoc Health, Inc. (TDOC) Q4 2024 Earnings Call Transcript
07:48pm, Wednesday, 26'th Feb 2025
Teladoc Health, Inc. (NYSE:TDOC ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Michael Minchak - Head of Investor Relations Chuck Divita - Chief Executive Officer
Here's What Key Metrics Tell Us About Teladoc (TDOC) Q4 Earnings
07:30pm, Wednesday, 26'th Feb 2025
While the top- and bottom-line numbers for Teladoc (TDOC) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compar
Teladoc (TDOC) Reports Q4 Loss, Tops Revenue Estimates
07:20pm, Wednesday, 26'th Feb 2025
Teladoc (TDOC) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.17 per share a year ago.
Teladoc's Earnings Miss as Revenue Falls
06:18pm, Wednesday, 26'th Feb 2025
Teladoc Health (TDOC -1.70%), a leader in telehealth services, released its fourth-quarter earnings on Feb. 26. The company reported revenue of $640.5 million, just above the $639 million that analyst
Teladoc shares tumble on wider-than-expected loss, disappointing revenue guidance
05:02pm, Wednesday, 26'th Feb 2025
Teladoc Health shares fell in extended trading on Wednesday after the company issued weak guidance and reported a bigger loss than expected. Revenue at the telehealth company decreased 3% in the fourt
Teladoc Health Reports Full Year and Fourth Quarter 2024 Results
04:05pm, Wednesday, 26'th Feb 2025
PURCHASE, NY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the full year ended December
Teladoc Health to Participate in Upcoming Investor Conference
04:30pm, Monday, 24'th Feb 2025
PURCHASE, NY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
03:30pm, Monday, 24'th Feb 2025
NEW YORK CITY, NY / ACCESS Newswire / February 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors
NEWTOWN, Pa. , Feb. 21, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Teladoc Health Inc. (NYSE: TDOC) resulting from alleg
What Analyst Projections for Key Metrics Reveal About Teladoc (TDOC) Q4 Earnings
10:21am, Friday, 21'st Feb 2025
Evaluate the expected performance of Teladoc (TDOC) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics
BOSTON, MA / ACCESS Newswire / February 21, 2025 / Block & Leviton is investigating Teladoc Health, Inc. (NYSE:TDOC) for potential securities law violations. Investors who have lost money in their Tel
Shares of Teladoc fell over 12% on February 20. Block & Leviton is investigating Teladoc for potential securities fraud. Investors should contact the firm.
